2002 Update of Recommendations for the Use of Chemotherapy and Radiotherapy Protectants: Clinical Practice Guidelines of the American Society of Clinical Oncology
Author:
Affiliation:
1. From the American Society of Clinical Oncology, Alexandria, VA.
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2002.04.178
Reference28 articles.
1. American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy Protectants
2. Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide.
3. Manegold C, Hans K, Bertrams J, et al: Comparison of the efficacy and tolerability of intravenous and intravenous/oral mesna: A randomized controlled multi-center phase III trial with mesna tablets. Proc Am Soc Clin Oncol 17: 46a,1998 (abstr 180)
4. Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
5. Seymour L, Bramwell V, Moran LA: Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer: The Provincial Systemic Treatment Disease Site Group. Cancer Prev Control 3: 145,1999-159,
Cited by 225 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiotoxicity in Pediatric AML;Pediatric Oncology;2024
2. A review on pulmonary and mediastinal synovial sarcoma;Journal of Basic and Clinical Physiology and Pharmacology;2023-02-20
3. Amifostine Silica Nanoparticles Characterization and Effect on Neuronal Damage in Cisplatin Treated Rats;Egyptian Journal of Chemistry;2023-02-01
4. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-11
5. Cisplatin Nephrotoxicity: Novel Insights Into Mechanisms and Preventative Strategies;Seminars in Nephrology;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3